Monika Stefańczyk, Head Pharmaceutical Analyst, PMR
The Romanian market is developing rapidly, particularly in the OTC subdivision, in which large pharmacy chains specialise. Growth is substantial because the base is relatively low – for example, per capita spending on OTCs is still half that of some other CEE countries such as Poland, and much lower than the figures seen in Western countries. The Romanian economy has experienced significant growth – with last year serving as a very good example, and an increasing number of people can afford to buy OTCs, which are not, unlike Rx, primary need products. In addition, there are no serious obstacles to…
PMR Insight: Recent substantial M&A transactions on the Romanian pharmacy market have not been random events
Sign up now to open the entire news item.You are allowed to open only one news item from PMR websites.
(to send requested information)
(required for new e-mails only)